Houlihan Lokey (NYSE: HLI) reported Q4 EPS of $0.96, $0.19 better than the analyst estimate of $0.77. Revenue for the quarter came in at $303 million versus the consensus estimate of $289.09 million.

COVID-19 Update

The COVID-19 pandemic has had a substantial negative effect on the global markets, and has created uncertainty, volatility and dislocation among a wide variety of sectors. The scale, scope and duration of the impact of the COVID-19 pandemic on our business, revenues and operating results is unpredictable and depends on many factors outside of our control. We note that revenues during the fourth quarter ended March 31, 2020 were negatively impacted by the COVID-19 pandemic and we expect it to continue to have an adverse effect on our business, revenues and operating results in the short term. However, while our CF revenues will be adversely impacted for an indeterminable period of time by the economic effects of COVID-19, we have seen an increase in the demand for services in our FR business.

For earnings history and earnings-related data on Houlihan Lokey (HLI) click here.